Klaria Pharma Holding AB: Klaria publishes prospectus relating to the rights issue and gives update regarding the level of undertaking of the rights issue
Klaria Pharma Holding AB (”Klaria” or the “Company") today announces that the prospectus relating to the Company's rights issue (the "Rights Issue") has been approved and registered by the Swedish Financial Supervisory Authority (the “SFSA”, sw. Finansinspektionen) (the "Prospectus"). The Company also announces that the Rights Issue of up to SEK 74.0 M before issuing costs has been secured up to 80 per cent by an increased top guarantee undertaking.Publication of the prospectus The prospectus that Klaria has prepared due to the upcoming rights issue has today been approved and registered